The clinical information you need, at your fingertips.
Medical News for You
N Engl J Med
Do inhaled glucocorticoids shorten the recovery time from COVID-19?
Systemic corticosteroids are beneficial for patients with severe COVID-19 who require hospitalization with supplemental oxygen, but the role of inhaled corticosteroids in those with mild to moderate COVID-19 symptoms is less clear …
FDA approves another SGLT2 inhibitor for adults with CKD
Empagliflozin (Jardiance) is now indicated to reduce the risk of sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with CKD at risk of progression. Approval was based on the phase 3 EMPA-KIDNEY trial, in which empagliflozin reduced the risk of kidney disease progression or CV death by 28% compared with placebo. The drug was also associated with a significant reduction in new or recurrent hospitalization compared with placebo.
U.S. women denied abortions for dangerous pregnancy problems sue 3 states
Women who were denied abortions despite serious medical problems, their doctors, and a medical association are suing the states of Idaho, Oklahoma, and Tennessee for not providing the care that they needed. The legal action follows a similar move by five women who sued Texas in March for denying abortions in cases of serious problems for both the woman and her fetus.
Hospitalizations rising: Your COVID-19 update for September 22, 2023
CDC reports that there were 20,538 new hospital admissions of patients with confirmed COVID-19 from September 3 through September 9—an increase of 7.7% from the previous week. Approximately 2.7% of deaths were due to COVID-19 from September 10 through September 16—an increase of 12.5% compared with the previous week.
Picture Quiz: A different kind of nasal drip
A woman in her 50s with hx of uncontrolled DM presented with nasal obstruction and right facial pain. She was treated empirically for sinusitis, with nasal steroids and saline wash. Ten days later, she presented to the ED with a black paranasal lesion. What’s the dx?
FDA OKs new simplified dosing regimen for Talicia
The recommended dosage of Talicia (omeprazole/amoxicillin/rifabutin) is now 4 capsules taken orally three times daily (at least four hours apart, e.g., morning, midday, and evening) with food. Previously, the recommended dosage interval was every 8 hours with food. According to the manufacturer, the new dosing and more flexible schedule should enable patients to follow a convenient "breakfast, lunch and dinner" dosing routine, which may support patient adherence and optimize the potential for H. pylori eradication.
TRENDING THIS WEEK